France Veterinary Healthcare Market Outlook 2031
The France veterinary healthcare market size was USD XX Billion in 2022 and is expected to reach USD XX Billion by 2031 register a considerable CAGR 4% during the forecast period, 2023–2031. The growth of the market is attributed to the rising of zoonotic infection in pet animals and livestock is driving the market growth.
Veterinary healthcare can be described as medical tests performed to protect the health and productivity of animals, as well as the early diagnosis and treatment of illness symptoms. The tests are carried out using a variety of techniques that include the use of blood, pee, stool, and biopsies from animals.
Veterinary diagnosis is used to diagnose a wide spectrum of animals, both wild and domestic. The industry's expansion is being accelerated by new forms of animal diseases and their subsequent transmission to people through animal interaction and animal foodstuff use. Veterinary medicine is defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals.
Besides, the increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market. Companion animal (CA) and food-producing animal (FPA) healthcare can be separated into two categories. Veterinarians offer medications, consultations, pet meals, and other items in the CA market. In the FPA market, veterinarians additionally provide public-sanctioned population medicine and hygienic monitoring.
France Veterinary Healthcare Market Trends, Drivers, Restraints, and Opportunities
- Rising customer emphasis on animal well-being and nutrition safety and growing pet ownership is anticipated to propel the market expansion during the forecast period.
- Increasing the output of farm animal products is required (beef, milk, eggs, and other dairy products) is a key factor spurring the market growth in the coming years.
- Constant rate of technological improvements and innovations in the creation of animal health medications is projected to fuel the market expansion during the forecast period.
- Growing demand for the farming area and a shortage of agricultural land are estimated to restrict the market growth.
- Rising expenses for veterinary care and animal testing act as a key challenge that can impede the market expansion in the coming years.
- Technological developments in veterinary health care are expected to offer lucrative opportunities for the market players.
Scope of The France Veterinary Healthcare Market Report
The report on the France veterinary healthcare market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Veterinary Healthcare Market - France Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Diagnostics [Clinical Chemistry, Molecular Diagnostics, Immunodiagnostic Tests, Diagnostic Imaging, and Others] and Therapeutics [Anti-infectives, Vaccines, Medical Feed Additives, Parasiticides, and Others]), Animal Types (Poultry, Swine, Ruminants, Dogs & Cats, and Horses)
|
|
Geographic Zone
|
France
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Zoetis Inc., Vetoquinol, Merck & Co. Inc., IDEXX Laboratories, Elanco, Ceva Animal Health, Inc., Boehringer Ingelheim International GmbH, and Bayer Healthcare
|
France Veterinary Healthcare Market Segment Insights
Vaccines segment is projected to hold a and key market share
Based on products, the France veterinary healthcare market is bifurcated into diagnostics and therapeutics. The therapeutics segment is further segmented into anti-infectives, vaccines, medical feed additives, parasiticides, and others. The vaccines by therapeutics segment are expected to represent a key share of the market in the coming years due to robust healthcare infrastructure and are seeing growth rates in R&D advances.
Inter-Governmental Agencies are reforming the monitoring and immunization processes to ensure public health. In the veterinary healthcare industry, the consciousness of pet health care and clinical diagnosis can also drive the market.
For instance, the diagnostics segment is further divided into clinical chemistry, molecular diagnostics, immunodiagnostic tests, diagnostic imaging, and others.
Poultry and Swine segments are expected to grow at a rapid pace
On the basis of animal types, the market is segregated into poultry, swine, ruminants, dogs & cats, and horses. The poultry and swine segment is expected to constitute a key share of the market during the forecast period owing to the demand for livestock goods is expanding in France's emerging nations.
Furthermore, increased considerations about food security and animal husbandry are expected to drive up demand for veterinary medications and vaccinations shortly. Meat consumption increased, especially in the case of pork and chicken.
Segments
The France veterinary healthcare market has been segmented based on
Products
- Diagnostics
- Clinical Chemistry
- Molecular Diagnostics
- Immunodiagnostic Tests
- Diagnostic Imaging
- Others
- Therapeutics
- Anti-infectives
- Vaccines
- Medical Feed Additives
- Parasiticides
- Others
Animal Types
- Poultry
- Swine
- Ruminants
- Dogs & Cats
- Horses
Key Players
- Zoetis Inc.
- Vetoquinol
- Merck & Co. Inc.
- IDEXX Laboratories
- Elanco
- Ceva Animal Health, Inc.
- Boehringer Ingelheim International GmbH
- Bayer Healthcare
Competitive Landscape
Key players competing in the France veterinary healthcare market include Zoetis Inc., Vetoquinol, Merck & Co. Inc., IDEXX Laboratories, Elanco, Ceva Animal Health, Inc., Boehringer Ingelheim International GmbH, and Bayer Healthcare. Some of these players are adopting several market strategies including acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to increase their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
